Internal Deadline (Application): Pfizer Quality Improvement Request for Proposal
Pfizer, the Lung Health Foundation (LHF), Lung Cancer Canada (LCC), and the Quebec Lung Association (QLA) are jointly issuing a Quality Improvement Request for Proposal (RFP). Grant funding and general oversight of the funded projects will be provided directly from Pfizer on behalf of Pfizer and the collaborators.
Submitted projects will be evaluated based on the criteria below. Eligible projects must be aimed at addressing health equity issues in metastatic NSCLC.
- Must address health equity issue for metastatic NSCLC
- Integration of input from individuals impacted by lung cancer
- Innovation & uniqueness
- Impact
- Methodology
- Feasibility (Capacity, leadership, sustainability & budget consideration)
Individual projects requesting up to $100,000 CAD will be considered. The estimated total available budget related to this RFP is $200,000 CAD.
Full details about this call are available here.
Internal Deadline: April 16, 2024. Contact email is ird@dal.ca
Funder Deadline: April 30, 2024. Contact is Don Rodriguez, Don.Rodriguez@pfizer.com with the subject line “2024 Oncology CAN LHF/LCC/QLA Lung QI.”
Time